Original Research
Published on 03 May 2024
Preclinical characterization of a novel investigational monoclonal antibody CM313 with potent CD38-positive cell killing activity
in Cancer Immunity and Immunotherapy
- 4,284 views
- 2 citations
Original Research
Published on 03 May 2024
in Cancer Immunity and Immunotherapy
Brief Research Report
Published on 03 May 2024
in Cancer Immunity and Immunotherapy
Case Report
Published on 03 May 2024
in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders
Original Research
Published on 03 May 2024
in Inflammation
Review
Published on 03 May 2024
in Inflammation
Original Research
Published on 03 May 2024
in Alloimmunity and Transplantation
Original Research
Published on 03 May 2024
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 03 May 2024
in Inflammation
Editorial
Published on 03 May 2024
in Microbial Immunology
Original Research
Published on 03 May 2024
in B Cell Biology
Original Research
Published on 03 May 2024
in Inflammation
Brief Research Report
Published on 03 May 2024
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 03 May 2024
in Immunological Tolerance and Regulation
Case Report
Published on 03 May 2024
in Cancer Immunity and Immunotherapy
Review
Published on 03 May 2024
in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders
Review
Published on 03 May 2024
in Cancer Immunity and Immunotherapy